Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N - Wikidata - wikimedia - TriplyDB

Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N

Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N

http://www.wikidata.org/entity/Q30357096

about

Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers Advances in HIV microbicide development Microbicides: a new hope for HIV prevention Designed oligomers of cyanovirin-N show enhanced HIV neutralization Escherichia coli surface display of single-chain antibody VRC01 against HIV-1 infection.Development of an HIV-1 Microbicide Based on Caulobacter crescentus: Blocking Infection by High-Density Display of Virus Entry Inhibitors.A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants.sCD4-17b bifunctional protein: extremely broad and potent neutralization of HIV-1 Env pseudotyped viruses from genetically diverse primary isolates.Development of an HIV-1 specific microbicide using Caulobacter crescentus S-layer mediated display of CD4 and MIP1alpha Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.Antiviral lectins as potential HIV microbicides Commensal bacteria modulate innate immune responses of vaginal epithelial cell multilayer cultures Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus.In vivo evaluation of safety and toxicity of a Lactobacillus jensenii producing modified cyanovirin-N in a rhesus macaque vaginal challenge model Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicide Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities.Vaginal microbiota and its role in HIV transmission and infection.Robust vaginal colonization of macaques with a novel vaginally disintegrating tablet containing a live biotherapeutic product to prevent HIV infection in women.A Chinese rhesus macaque (Macaca mulatta) model for vaginal Lactobacillus colonization and live microbicide development.The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.Demonstration of vaginal colonization with GusA-expressing Lactobacillus jensenii following oral delivery in rhesus macaques.Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?Rational design of novel HIV-1 entry inhibitors by RANTES engineering Engineering of a human vaginal Lactobacillus strain for surface expression of two-domain CD4 molecules Rhizosecretion improves the production of Cyanovirin-N in Nicotiana tabacum through simplified downstream processing Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection.Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria.Vaginal drug delivery systems for HIV prevention.Non-Antiretroviral Microbicides for HIV Prevention.Expression of Human Immunodeficiency Virus Type 1 Neutralizing Antibody Fragments Using Human Vaginal Lactobacillus.Mucosal Lactobacillus vectored vaccines.Potential of carbohydrate-binding agents as therapeutics against enveloped viruses.Engineering antibiotic production and overcoming bacterial resistance.Bio-inspired, bioengineered and biomimetic drug delivery carriers.Lectins with anti-HIV activity: a review.Human lectins and their roles in viral infections.Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects.The Tetrameric Plant Lectin BanLec Neutralizes HIV through Bidentate Binding to Specific Viral Glycans.Cyanovirin-N produced in rice endosperm offers effective pre-exposure prophylaxis against HIV-1BaL infection in vitro.

P2860

Q24620129-F4E7254C-7A4C-4EC7-B5C1-E0FE950E3411 Q26852858-F1164321-EE57-4A9B-A1A3-B3623B795F15 Q27022779-B3E241C4-E0D1-48C3-95C1-1A784D21790E Q27671182-A6628C88-7DC5-43C3-84E9-A7C160CC263D Q30153279-0BAA2B7E-4065-4F9E-B98F-448B08A6FAAC Q30351993-CE5B8F3E-4CD6-4F94-92AD-EC442F2DC740 Q30369008-5AA16589-67A1-4DB6-935A-DB26333EC1B3 Q30378613-09608023-FBDC-4ADD-B505-42BE29DF0CF9 Q33348658-07929136-F02B-4029-A838-0D09C8801340 Q33815944-AF98EFDC-7437-4AE5-B9DD-7CE02C47B37B Q33821090-F902FC26-B5F7-4D14-A0FF-F1D370A03277 Q34112159-69ED5CCD-3992-4DB8-A5A5-14625F0CE195 Q34193360-BAC53F19-F5C7-4CD7-9BEB-D2C773843D9C Q34198191-00309CFF-1049-4110-843E-A4ED39A6C9B7 Q34387113-7FDF4F04-D1CA-483E-8003-72F45D97F9B3 Q34539354-7186542F-50D3-4E1F-943D-5D62C74125F2 Q34548621-97609D27-6DC2-4CA9-9C57-59EDFD6BE263 Q34780332-2D40733A-59DC-41EF-A025-670F3F3E682C Q35415972-73687169-18BF-4986-B280-81F26E45D7B6 Q35575950-CF04B389-7114-4E44-8C5B-416F8E19B583 Q35743210-B20BC29B-43D8-4956-8BB3-A3CDC3CF88E5 Q36254221-A46B907F-F675-4911-82A1-42A5D264AAD4 Q36758492-8F7C7D9C-963F-4557-9827-DC5A5C2394B7 Q36793736-01439EF1-3F86-45C2-9E94-BD838A249AC6 Q36824239-671BAD91-F917-490E-BDA9-4D671E618A0A Q37056391-DD00CF25-AAB4-47B3-A6E5-013460F374BE Q37088591-3DE705E4-984D-4FAC-BB0E-DDE64EBD1974 Q37111626-619C11F4-E150-4E0E-8592-79991AA5B99B Q37149107-5465ED61-C56F-41D0-AE3C-C30009DE5D62 Q37317845-D51DE763-0D79-4E0D-B556-AAD2AA892D36 Q37346068-4A5778D3-6E36-4608-82D6-DAF397B40667 Q37521871-9B8F3A9D-6755-432F-AA61-B801CF8734A0 Q37767654-82DFAAC6-C0A0-46CB-B96D-46967B7B164B Q37887690-F1871A97-C910-4E5B-94CA-EA53B3AE3E21 Q37896455-CD8AF8BD-32D4-4B8E-8F05-B10716F0EC11 Q38311332-C9C97706-03DD-420D-BC71-DD162D102FD3 Q38340871-0EC3C9A6-B1C2-495B-A34A-9DEF2B2CA730 Q38806283-0CB1C13B-CCC0-4F79-AD7E-83D5ECAF9A2C Q40231057-B1E77600-9F16-4CA3-8663-9F86F415DFC8 Q40743773-3CB449E9-9142-41D6-A0AD-384320F7CD9B

P2860

Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N

http://www.wikidata.org/entity/Q30357096

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Engineered vaginal lactobacill ...... y virus inhibitor cyanovirin-N

@ast

Engineered vaginal lactobacill ...... y virus inhibitor cyanovirin-N

@en

type

label

Engineered vaginal lactobacill ...... y virus inhibitor cyanovirin-N

@ast

Engineered vaginal lactobacill ...... y virus inhibitor cyanovirin-N

@en

prefLabel

Engineered vaginal lactobacill ...... y virus inhibitor cyanovirin-N

@ast

Engineered vaginal lactobacill ...... y virus inhibitor cyanovirin-N

@en

P1433

Q30357096-A06F55A6-C362-4C5A-91A4-CF03A15101FC

P1476

Q30357096-7732B605-C767-4442-AD9F-5A58BF0CB087

P2093

Q30357096-021182DD-7204-470D-A1D0-C270D579605B

Q30357096-29097906-A5CC-4718-9472-E9C1F53193C6

Q30357096-46080BDC-A1CE-4D1F-9532-8DE0DEB7E498

Q30357096-6527B444-BBB6-4C49-93E8-13E9BE09AFAF

Q30357096-6E3F4593-1021-499B-8D5E-15D0338DF08E

Q30357096-82FB6297-DCE7-477D-A9F3-1DC52AC20A6E

Q30357096-8C64409D-E430-4A0A-9D6F-FBE674923750

Q30357096-B3722B9E-722A-4769-98F7-C7727E073931

Q30357096-B50B5DA4-3960-43F3-83E1-8B0960939A7F

Q30357096-D212321C-4E2C-4402-A4B7-C7C62916F5BC

P2860

Q30357096-0C5A2FB0-A1D5-4522-8BA0-5DEF90B1D15D

Q30357096-14E72F87-70FA-4889-AE8F-FF7CC28B1723

Q30357096-1CF7668E-0A4D-4616-9384-30FC9F4F6BAE

Q30357096-30B30A0B-FD55-4BFC-856B-2A34127E6249

Q30357096-36540377-1985-4ABA-A185-C1932897DAF7

Q30357096-37604648-8BCE-4DB1-8BF0-996049393559

Q30357096-387F3A00-B0DC-41D7-A292-9BBFF5F79132

Q30357096-3B0F22A7-F746-4AA3-AB6C-D612F96234EF

Q30357096-40120C6C-1C1A-4F72-BE55-B0868D68EC45

Q30357096-410C3C5F-7CB4-4135-A515-946FD4ED4FC3

P304

Q30357096-6CAB2589-D559-417F-B469-51A88DD589A2

P31

Q30357096-419D5265-BDDE-4DF7-92F3-25D380C09E5B

P356

Q30357096-E60F6138-A82A-4273-A428-B2C84A7DB9D0

P407

Q30357096-0B99996F-EACC-4042-9CBA-A0ECC1965809

P433

Q30357096-FCEFBC44-324A-44FD-9208-84405B792398

P478

Q30357096-108EB42A-E444-4CE2-87FB-D2759B257111

P50

Q30357096-63AE81BD-53DB-4FF9-906E-F20C3D25F5ED

P577

Q30357096-F6F66C16-A793-4BBD-8166-36E87063B925

P5875

Q30357096-BFEEF1C4-6237-48EE-992C-02C491DC5AA9

P698

Q30357096-E0587CCF-330A-4419-ABD4-DCC07E7C8EC3

P932

Q30357096-C5169234-D433-4BDF-A0DE-8EA1813A92C5

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Engineered vaginal lactobacill ...... y virus inhibitor cyanovirin-N

@en

P2093

Courtney L Frazier-Parker

http://www.w3.org/2001/XMLSchema#string

Daniel Tsai

http://www.w3.org/2001/XMLSchema#string

David A Simpson

http://www.w3.org/2001/XMLSchema#string

Dean H Hamer

http://www.w3.org/2001/XMLSchema#string

Kirsten P Essenmacher

http://www.w3.org/2001/XMLSchema#string

Laurel A Lagenaur

http://www.w3.org/2001/XMLSchema#string

Qiang Xu

http://www.w3.org/2001/XMLSchema#string

Srinivas S Rao

http://www.w3.org/2001/XMLSchema#string

Thomas P Parks

http://www.w3.org/2001/XMLSchema#string

Xiaowen Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533

Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide.

Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites

Whole-genome random sequencing and assembly of Haemophilus influenzae Rd

The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species

Vaginal lactobacillus flora of healthy Swedish women

Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides

Characterization and functional analysis of the poxB gene, which encodes pyruvate oxidase in Lactobacillus plantarum.

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

P304

3250-3259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00493-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6788502

http://www.w3.org/2001/XMLSchema#string

P698

17005802

http://www.w3.org/2001/XMLSchema#string

P932

1610104

http://www.w3.org/2001/XMLSchema#string